A conceptual exploration of the strategic factors driving new brand entry decisions and their success
Keywords: New brands; RBV; Strategic orientation; Environment; Innovation
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
Keywords: cEVR; complete early virologic response; ETR; end of treatment response; PegIFN; pegylated interferon; RBV; ribavirin; RVR; rapid virologic response; SVR; sustained virologic response;
Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate
Keywords: Adverse Effects of Hepatitis Therapy; Clinical Trial; Liver Disease; Blood Disorders; AE; adverse event; EOT; end of treatment; ESA; erythropoiesis-stimulating agent; Hb; hemoglobin; HCV; hepatitis C virus; IDEAL; Individualized Dosing Efficacy vs Flat Do
Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
Keywords: ISDR; IRRDR; Genetic Analysis; Genetic Variations; DW; double-wild; ETR; end of treatment response; HCV; hepatitis C virus; IRRDR; interferon/ribavirin resistance-determining region; ISDR; interferon sensitivity-determining region; ISG; interferon-stimula
IL28B and the Control of Hepatitis C Virus Infection
Keywords: IL28B; Hepatitis C Virus; Interferon Lambda; Interferon Sensitivity; HCV Treatment; GWAS; genome-wide association studies; HIV; human immunodeficiency virus; IFN; interferon; IL-10Rβ; interleukin-10 receptor beta chain; IL-28Rα; interleukin-28 receptor
What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: Viral dynamics, viral levels at certain time points, or a combination of both?
Keywords: HCV; hepatitis C virus; PEG-IFN; pegylated interferon; RBV; ribavirin; CHC; chronic hepatitis C; SVR; sustained virologic response; NPV; negative predictive value; PPV; high positive predictive value; VD; viral decline; VL; viral load;
Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C
Keywords: AEs; adverse events; alb-IFN; albinterferon alfa-2b; ANC; absolute neutrophil count; CES-D; Center for Epidemiologic Studies Depression scale; CHC; chronic hepatitis C; Gt; genotype; HCV; hepatitis C virus; LOD; limit of detection; PEG-IFN; pegylated inte
Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation
Keywords: SLK; simultaneous liver-kidney transplant; MELD; model for end-stage liver disease; HCV+; hepatitis C virus positive; LTA; liver transplant alone; IFN; interferon; RBV; ribavirin; RRT; renal replacement therapy; SVR; sustained viral response; ICU; inten
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C
Keywords: HCV; hepatitis C virus; PEG-IFN; pegylated interferon; RBV; ribavirin; CHC; chronic hepatitis C; RIVR; rapid initial virologic response rate; SVR; sustained virologic response; NPV; negative predictive value; PPV; high positive predictive value; albIFN; a
Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy
Keywords: AFP; alpha fetoprotein; AGA; American Gastroenterological Association; ALT; alanine aminotransferase; APRI; aspartate aminotransferase platelet ratio index; AUROC; area under the receiver operator characteristics; CI; confidence interval; CT; computed tom
Clinical Significance of Metabolic Syndrome in the Setting of Chronic Hepatitis C Virus Infection
Keywords: BMI; body mass index; CI; confidence interval; DM; diabetes mellitus; HCV; hepatitis C virus; HDL; high-density lipoprotein; HOMA; homeostasis model of assessment; HVL; high baseline viral load; IR; insulin resistance; MS; metabolic syndrome; PEG IFN; peg
Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients
Keywords: AE; adverse event; alb-IFN; albinterferon alfa-2b; ANC; absolute neutrophil count; BMI; body mass index; CHC; chronic hepatitis C; ETR; end-of-treatment response; Hb; hemoglobin; HOMA-IR; homeostasis model assessment of insulin resistance; IFN; interferon
Latinos and Chronic Hepatitis C: A Singular Population
Keywords: CHC; chronic hepatitis C; HCC; hepatocellular carcinoma; HIV; human immunodeficiency virus; IDU; injecting drug use; IFN; interferon; IR; insulin resistance; RBV; ribavirin; RVR; rapid virologic response; SVR; sustained virologic response;
Insulin Resistance Among Patients With Chronic Hepatitis C: Etiology and Impact on Treatment
Keywords: BMI; body mass index; CHC; chronic hepatitis C; DM; diabetes mellitus; EVR; early virologic response; G; genotype; GLUT; glucose transport protein; HCV; hepatitis C virus; HOMA-IR; homeostasis model of assessment for insulin resistance; HOMA-β; homeostas
Analysis of interactions among core, transaction and relationship-specific investments: The case of offshoring
Keywords: Offshoring; TCE; RBV; Core specificity; Relationship investment
Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
Keywords: ALT; alanine aminotransferase; B; baseline; BR; biochemical response; CyA; cyclosporine A; EVR; early virological response; FCH; fibrosing cholestatic hepatitis; FU; follow-up; HBV; hepatitis B virus; HCV; hepatitis C virus; HIV; human immunodeficiency vi
Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population
Keywords: ALT; alanine aminotransferase; ETVR; end of treatment virologic response; HCV; hepatitis C virus; IDU; intravenous drug user; IFN; interferon alfa-2a/2b; MSM; men who have sex with men; PEG-IFN; pegylated interferon alfa-2a/2b; RBV; ribavirin; SVR; sustai
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Keywords: HCV; hepatitis C virus; IFN; interferon; PEG; pegylated; RBV; ribavirin; SVR; sustained virologic response;
Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; GMA; granulocytes and monocytes/macrophage apheresis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IFN; interferon; RBV; ribavirin; RT nested-PCR; reverse transcription nested polym
Management of hepatitis C virus in special populations: Patient and treatment considerations
Keywords: ESLD; end-stage liver disease; HAART; highly active antiretroviral therapy; HCC; hepatocellular carcinoma; HIV; human immunodeficiency virus; IFN; interferon; IVDU; intravenous drug user; NHANES; National Health and Nutrition Examination Survey; NIH; Nati
Erythropoietic Growth Factors for Treatment-Induced Anemia in Hepatitis C: A Cost-Effectiveness Analysis
Keywords: EGF; erythropoietic growth factor; EVR; early virologic response; HCV; hepatitis C virus; Hgb; hemoglobin; HRQOL; health-related quality of life; ICER; incremental cost-effectiveness ratio; PEG-IFN; pegylated interferon; QALY; quality-adjusted life-year;
Monti and Market Dynamics:
Keywords: Highly dynamic markets; RBV; Monti; Deregulation in the European automative industry;